NCT00772577 - Study of the Efficacy and Safety of Aliskiren HCTZ vs Ramipril in Obese Patients (BMI ≥ 30) With Stage 2 Hypertension | Biotech Hunter

Enrollment

386

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions

Hypertension

Interventions

DRUG

Aliskiren Hydrochlorothiazide

Aliskiren HCTZ 150/12.5 mg: 1 week; Aliskiren HCTZ 300/25 mg: 7 weeks

DRUG

Ramipril

Ramipril 5mg: 1 week; Ramipril 10 mg: 7 weeks

Trial Locations (6)

Investigative Site, Beverly Hills

Investigative Site, Santa Ana

Investigative Site, Conyers

Investigative Site, Lexington

Investigative Site, Columbia

Investigative Site, Houston